Anti-Caspase-9 antibody [E84]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(21 Publications)
Rabbit Recombinant Monoclonal Caspase-9 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 21 publications.
View Alternative Names
MCH6, CASP9, Caspase-9, CASP-9, Apoptotic protease Mch-6, Apoptotic protease-activating factor 3, ICE-like apoptotic protease 6, APAF-3, ICE-LAP6
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E84] (AB32068)
Immunohistochemical analysis of paraffin-embedded human colon adenocarcinoma using anti-Pro-Caspase-9 RabMAb (ab32068).
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Unknown
Western blot - Anti-Caspase-9 antibody [E84] (AB32068)
Blocking/dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-Caspase-9 antibody [E84] (ab32068) at 1/1000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 20 µg
Lane 2:
HeLa treated with staurosporine 1uM for 4 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 46 kDa
Observed band size: 35 kDa,37 kDa,46 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-Caspase-9 antibody [E84] (AB32068)
Lanes :
Lane 1 : Wild-type HAP1 whole cell lysate (40 μg).
Lane 2 : CASP9 knockout HAP1 whole cell lysate (40μg).
Lane 3 : HeLa whole cell lysate (40 μg).
Lanes 1 - 3 Merged signal (red and green). Green - ab32068 observed at 45 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab32068 was shown to specifically recognize CASP9 in wild-type HAP1 cells along with additional cross-reactive bands. No band was observed when CASP9 knockout samples were examined. Wild-type and CASP9 knockout samples were subjected to SDS-PAGE. ab32068 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/500 dilution and 1/10,000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Caspase-9 antibody [E84] (ab32068)
Predicted band size: 46 kDa
false
- WB
Unknown
Western blot - Anti-Caspase-9 antibody [E84] (AB32068)
All lanes:
Western blot - Anti-Caspase-9 antibody [E84] (ab32068) at 1/2000 dilution
All lanes:
Jurkat cell lysate at 10 µg
Predicted band size: 46 kDa
Observed band size: 46 kDa
false
Related conjugates and formulations (1)
-
Anti-Caspase-9 antibody [E84] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
British journal of pharmacology 182:3923-3951 PubMed40344208
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer communications (London, England) 44:408-432 PubMed38407943
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 25:259 PubMed37153902
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 48: PubMed35730618
2022
Applications
Unspecified application
Species
Unspecified reactive species
Bioengineered 12:6070-6082 PubMed34488535
2021
Applications
Unspecified application
Species
Unspecified reactive species
Artificial cells, nanomedicine, and biotechnology 47:1758-1765 PubMed31062616
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biochemistry 456:63-72 PubMed30644017
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and molecular pathology 106:109-115 PubMed30594603
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of immunopathology and pharmacology 32:2058738418814341 PubMed30477356
2018
Applications
Unspecified application
Species
Unspecified reactive species
Molecules and cells 41:401-412 PubMed29754474
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com